Briefly, 37 patients (53%) were males, the median age was 61 years (range, 27–91 years), 19 (24%) patients had brain metastases, 59 (76%) had BRAF wild-type melanoma and 16 (21%) had BRAF mutations, while BRAF status was not known for 3 patients. Here, BRAF is linked to melanoma.